Medpace Holdings, Inc.

Healthcare · Diagnostics & Research · United States

Last price 652.01 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 18.24B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data man...